Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke
Authors:
- Joan Martí-FàbregasJMJoan Martí-Fàbregas
- Daniel Guisado-AlonsoDGDaniel Guisado-Alonso
- Raquel Delgado-MederosRDRaquel Delgado-Mederos
- Luis Prats-SánchezLPLuis Prats-Sánchez
- Marina Guasch-JiménezMGMarina Guasch-Jiménez
- Pere CardonaPCPere Cardona
- Manuel RequenaMRManuel Requena
- Marta RubieraMRMarta Rubiera
- Marta OlivéMOMarta Olivé
- Alejandro BustamanteABAlejandro Bustamante
- 30 August 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 52 (12) , 3908-3917
Abstract
Background and Purpose: We evaluated whether stroke severity, functional outcome, and mortality are different in patients with ischemic stroke with or without coronavirus disease 2019 (COVID-19) infection. Methods: A prospective, observational, multicentre cohort study in Catalonia, Spain. Recruitment was consecutive from mid-March to mid-May 2020. Patients had an acute ischemic stroke within 48 hours and a previous modified Rankin Scale (mRS) score of 0 to 3. We collected demographic data, vascular risk factors, prior mRS score, National Institutes of Health Stroke Scale score, rate of reperfusion therapies, logistics, and metrics. Primary end point was functional outcome at 3 months. Favourable outcome was defined depending on the previous mRS score. Secondary outcome was mortality at 3 months. We performed mRS shift and multivariable analyses. Results: We evaluated 701 patients (mean age 72.3±13.3 years, 60.5% men) and 91 (13%) had COVID-19 infection. Median baseline National Institutes of Health Stroke Scale score was higher in patients with COVID-19 compared with patients without COVID-19 (8 [3–18] versus 6 [2–14], P =0.049). Proportion of patients with a favourable functional outcome was 33.7% in the COVID-19 and 47% in the non-COVID-19 group. However, after a multivariable logistic regression analysis, COVID-19 infection did not increase the probability of unfavourable functional outcome. Mortality rate was 39.3% among patients with COVID-19 and 16.1% in the non-COVID-19 group. In the multivariable logistic regression analysis, COVID-19 infection was a risk factor for mortality (hazard ratio, 3.14 [95% CI, 2.10–4.71]; P <0.001). Conclusions: Patients with ischemic stroke and COVID-19 infection have more severe strokes and a higher mortality than patients with stroke without COVID-19 infection. However, functional outcome is comparable in both groups.Keywords
This publication has 31 references indexed in Scilit:
- Mild or Moderate Covid-19New England Journal of Medicine, 2020
- Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and MortalityJAMA Cardiology, 2020
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-UpJACC, 2020
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, ChinaJAMA Neurology, 2020
- Temporary Emergency Guidance to US Stroke Centers During the Coronavirus Disease 2019 (COVID-19) PandemicStroke, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- Endothelial cell infection and endotheliitis in COVID-19The Lancet, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Early Prediction of Outcome of Activities of Daily Living After StrokeStroke, 2011
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993